Showing results (51-60 of 111) with videos related to
Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junctionKatja Ott, Wolfgang A Weber, Florian Lordick, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2013
Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junctionMarc-André Weber, Karen Bender, Carl Christian von Gall, et al.Oncology Letters|December 2, 2015
Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancerLeila Sisic, Daniel Vallböhmer, Nikolas H Stoecklein, et al.BMC Cancer|February 5, 2014
A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patientsSusanne Blank, Sivaramakrishna Rachakonda, Gisela Keller, et al.Annals of Surgical Oncology|June 2, 2018
Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric AdenocarcinomasUlrike Heger, Leila Sisic, Henrik Nienhüser, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2007
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junctionHinrich A Wieder, Katja Ott, Florian Lordick, et al.Langenbeck'S Archives of Surgery|November 20, 2014
Outcome, complications, and mortality of an intrathoracic anastomosis in esophageal cancer in patients without a preoperative selection with a risk scoreIngo Alldinger, Leila Sisic, Marcel Hochreiter, et al.Oncotarget|September 13, 2014
Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapyMichaela Aichler, Martin Motschmann, Uta Jütting, et al.Emergency Radiology|May 9, 2014
Emergency embolization for the treatment of acute hemorrhage from intercostal arteriesUlrike Stampfl, Christof-Matthias Sommer, Nadine Bellemann, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
PET imaging with [11C]methyl- L-methionine for therapy monitoring in patients with rectal cancerHinrich Wieder, Katja Ott, Frank Zimmermann, et al.Pageof 12